[Criteria of treatment and prognosis in hypertrophic obstructive cardiomyopathy, obtained from electrocardiographic and catamnestic studies].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology; D002118:Calcium / Q000037:antagonists & inhibitors; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000628:therapy*; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002118:Calcium
Criteri di trattamento e prognosi delle cardiomiopatie ipertrofico-ostruttive derivati dallo studio elettrocardiografico e catamnestico.